Melatonin promotes sleep in mice by inhibiting orexin neurons in the perifornical lateral hypothalamus
- 14 April 2018
- journal article
- research article
- Published by Wiley in Journal of Pineal Research
- Vol. 65 (2) , e12498
Abstract
Melatonin promotes sleep. However, the underlying mechanisms are unknown. Orexin neurons in the perifornical lateral hypothalamus ( PFH ) are pivotal for wake promotion. Does melatonin promote sleep by inhibiting orexin neurons? We used C57 BL /6J mice and designed 4 experiments to address this question. Experiment 1 used double‐labeled immunofluorescence and examined the presence of melatonin receptors on orexin neurons. Second, mice, implanted with bilateral guides targeted toward PFH and sleep‐recording electrodes, were infused with melatonin (500 pmole/50 nL/side) at dark onset (onset of active period), and spontaneous bouts of sleep‐wakefulness were examined. Third, mice, implanted with bilateral guides into the PFH , were infused with melatonin (500 pmole/50 nL/side) at dark onset and euthanized 2 hours later, to examine the activation of orexin neurons using c‐Fos expression in orexin neurons. Fourth, mice, implanted with PFH bilateral guides and sleep‐recording electrodes, were infused with melatonin receptor antagonist, luzindole (10 pmol/50 nL/side), at light onset (onset of sleep period), and spontaneous bouts of sleep‐wakefulness were examined. Our results suggest that orexin neurons express MT 1, but not MT 2 receptors. Melatonin infusion into the PFH , at dark onset, site‐specifically and significantly increased NREM sleep (43.7%, P = .003) and reduced wakefulness (12.3%, P = .013). Local melatonin infusion at dark onset inhibited orexin neurons as evident by a significant reduction (66%, P = .0004) in the number of orexin neurons expressing c‐Fos. Finally, luzindole infusion‐induced blockade of melatonin receptors in PFH at sleep onset significantly increased wakefulness (44.1%, P = .015). Based on these results, we suggest that melatonin may act via the MT 1 receptors to inhibit orexin neurons and promote sleep.Keywords
Funding Information
- U.S. Department of Veterans Affairs (I01BX002661)
This publication has 87 references indexed in Scilit:
- Melatonin and its analogs in insomnia and depressionJournal of Pineal Research, 2012
- Insomnia and the Performance of US Workers: Results from the America Insomnia SurveySLEEP, 2011
- Pharmacogenetic Modulation of Orexin Neurons Alters Sleep/Wakefulness States in MicePLOS ONE, 2011
- Sleep and its regulation in zebrafishReviews in the Neurosciences, 2011
- Role of adenosine and wake‐promoting basal forebrain in insomnia and associated sleep disruptions caused by ethanol dependenceJournal of Neurochemistry, 2010
- Role of Wake‐Promoting Basal Forebrain and Adenosinergic Mechanisms in Sleep‐Promoting Effects of EthanolAlcohol, Clinical and Experimental Research, 2010
- Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the ratNeuroscience Letters, 2009
- Effect of microdialysis perfusion of 4,5,6,7-tetrahydroisoxazolo-[5,4-c]pyridine-3-ol in the perifornical hypothalamus on sleep–wakefulness: Role of δ-subunit containing extrasynaptic GABAA receptorsNeuroscience, 2008
- Effects of Saporin-Induced Lesions of Three Arousal Populations on Daily Levels of Sleep and WakeJournal of Neuroscience, 2007
- Orexins Activate Histaminergic Neurons via the Orexin 2 ReceptorBiochemical and Biophysical Research Communications, 2002